Rare diseases
Investigational molecules
Locations
Bdul Carol I, Nr. 50, 700503 Iasi, Romania
CMI DIABET TOARBA CRISTINA IOANA in Iasi, Romania specialises in clinical trials of conditions such as Obesity, Overweight, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.
At CMI DIABET TOARBA CRISTINA IOANA, researchers are dedicated to advancing care for patients with excess weight and related metabolic conditions.
Current studies evaluate the investigational peptide olatorepatide for its ability to promote meaningful weight reduction in individuals with obesity, both with and without type 2 diabetes. These trials aim to demonstrate superior efficacy compared with placebo, potentially offering a new option for weight loss and metabolic improvement.
Clinical trials registered at this site – none is enrolling right now.
Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
RomaniaEfficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
RomaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
